| Treatment group | Control group |
Patients with recurrence during 0 m - 3 m follow-up | 5(13.5%)* | 9(32.1%) |
Patients with recurrence during 3 m - 6 m follow-up | 2(5.4%)* | 4(14.3%) |
Total patients with recurrence | 7(18.9%)* | 13(46.4%) |